Specialized palliative care intervention enrollment patterns in a glioblastoma randomized controlled trial sub-analysis
Glioblastoma trial reveals why patients skip or delay visits
This sub-analysis of the Early Palliative Care for Patients with Glioblastoma (EPCOG) trial examined enrollment and retention among 556 scre…
Many glioblastoma patients skip or delay study visits due to illness or lack of interest, a new trial analysis finds.
Narrative review suggests multi-omics AI models improve glioma radiotherapy response prediction over single-modality approaches
Glioma Radiotherapy Gets Smarter With Biomarker-Guided Dosing
This narrative review synthesizes evidence regarding multi-omics artificial intelligence models for predicting radiotherapy response in glio…
New biomarkers may help doctors tailor radiation doses for glioma patients, improving outcomes and reducing side effects.
Adjuvant Imatinib Beyond 3 Years in High-Risk GIST: 5-Year Relapse-Free Survival Outcomes
Extending Imatinib beyond 3 years did not improve survival for high-risk GIST patients
This retrospective cohort study evaluated adjuvant imatinib duration in 75 patients with high-risk GIST after radical surgery.
A look at past data shows taking Imatinib longer than three years did not help high-risk GIST patients live longer or stay cancer-free.
Taxane-Based and Long-Course Chemotherapy Linked to Higher Breast Cancer-Related Lymphedema Risk
New Data Links Chemo Drugs to Arm Swelling in Breast Cancer
In a retrospective cohort of 201 breast cancer patients at Guangzhou Red Cross Hospital, taxane-based regimens, long-course chemotherapy, an…
Breast cancer patients on certain chemotherapy drugs face a higher risk of developing arm swelling after treatment ends.
3D C-Vit model improves tumor grading accuracy in 340 pediatric brain tumor cases
New AI Tool Grades Pediatric Brain Tumors With 91% Accuracy
This retrospective cohort review evaluated a 3D C-Vit model against clinical and radiomics models in 340 pediatric brain tumor cases.
A new AI tool grades pediatric brain tumors with 91% accuracy, helping doctors plan treatment faster and more reliably.
Dried blood spot metabolomics shows promising breast cancer detection performance in 2,734 participants
Finger-Prick Test Spots Breast Cancer Early
This cohort study evaluated untargeted metabolomic profiling of dried blood spots for breast cancer detection among 2,734 participants (114 …
A new at-home style blood test can spot breast cancer with just a finger prick, offering hope for earlier detection without clinic visits.
CPX-351 first-line therapy shows 61% overall response in therapy-related AML or AML with myelodysplastic-related changes
New AML Drug Shows Strong Response But Some Patients Face Higher Risk
This retrospective monocentric cohort study evaluated 60 consecutive patients treated with CPX-351 as first-line therapy for therapy-related…
A new leukemia drug helps most patients respond well, but those with high white blood cell counts or complex gene changes may face higher ri…
Prognostic Nutritional Index and HALP Score Predict Lymph Node Metastasis in Breast Cancer
Low nutrition score predicts lymph node spread in breast cancer cases
This cohort study of 799 breast cancer patients found that 51.6% had lymph node metastasis (LNM).
A simple nutrition score predicts if breast cancer has spread to lymph nodes, helping doctors plan better care.
QDB method shows higher consistency than IHC for HER2 assessment in invasive breast cancer
New Test Finds Hidden Breast Cancer Targets
This observational cohort study compared a Quantitative Dot Blot (QDB) method to immunohistochemistry (IHC) for HER2 assessment in patients …
Some women told their breast cancer lacks a key target may actually benefit from powerful drugs — a new test can finally tell the difference…
NDRG4 methylation in blood leukocytes associated with gastric cancer risk and prognosis in a case-control study
Blood test reveals hidden risk factor for stomach cancer survival
This case-control study evaluated methylation of the NDRG4 gene in peripheral blood leukocytes among 310 gastric cancer patients and 300 con…
A simple blood test can now predict stomach cancer risk and how well chemotherapy will work for patients.
Qualitative review of tocilizumab use with bispecific antibodies in relapsed/refractory multiple myeloma
New drugs for myeloma need a safety net to work well
This qualitative interview review synthesizes perspectives from ten hematologists/oncologists regarding bispecific antibody (BsAb) use in…
New powerful drugs treat myeloma better, but patients need a safety net to handle side effects and stay on track for a long time.
Software validation report shows single biomarkers often outperform panels for breast cancer diagnosis
New Tool Finds the Tipping Point in Cancer Tests
This software validation report evaluates the TholdStormDX v0.0.1 tool across four diagnostic domains.
A new tool could help doctors decide exactly when a test result means cancer is likely — cutting down on missed cases and false alarms.